5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate,
5-bromo-6-(imidazolidinylideneamino)quinoxaline,
5-bromo-6-(imidazolin-2-ylamino)quinoxaline,
AGN 190342,
AGN-190342,
AGN190342,
Alphagan,
Alphagan P,
brimonidine,
brimonidine Purite,
brimonidine tartrate,
brimonidine tartrate (1:1),
brimonidine tartrate (1:1), (S-(R*,R*))-isomer,
brimonidine tartrate, (R-(R*,R*))-isomer,
bromoxidine,
mirvaso,
Ratio Brimonidine,
ratio-Brimonidine,
Sanrosa,
UK 14,304,
UK 14,304 18,
UK 14,304-18,
UK 14,30418,
UK 14,308,
UK 14304,
UK 14308,
UK-14,304-18,
UK-14,308,
UK-14304,
UK14,30418,
UK14,308,
UK14304,
BRIMONIDINE TARTRATE,
70359-46-5,
Brimonidine tartarate,
Brominide tartrate,
Alphagan,
Brimonidine D-tartrate,
UNII-4S9CL2DY2H,
Brimonidinne tartrate,
C11H10BrN5.C4H6O6,
Brimonidine L-Tartrate,
Brimonidine (tartrate),
Brimonidine D-tartarate,
4S9CL2DY2H,
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate,
UK-14304-18,
Qoliana,
(5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1h-imidazol-2-yl)-amine L-tartrate,
brimonidine Purite,
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; (2R,3R)-2,3-dihydroxybutanedioic acid,
59803-99-5,
Brimonidine tartrate [USAN],
AGN-190342-LF,
Alphagan-P,
AGN 190342LF,
Brimonidine tartrate [USAN:JAN],
N-(5-bromoquinoxalin-6-yl)imidazolidin-2-imine;(2R,3R)-2,3-dihydroxybutanedioic acid,
Alphagan (TN),
brimonidine-tartrate,
5-bromo-N-,
UK14304 tartrate,
AC1L1GYC,
AGN190342 tartrate,
AC1Q59OR,
UK 14,304 (tartrate),
SCHEMBL265607,
HY-B0659A,
Brimonidine tartrate (JAN/USAN),
HMS3715P18,
AGN 190342-LF,
ACT08633,
EBD23481,
KS-00000K6V,
MFCD07773072,
AKOS016845265,
CCG-221278,
CS-4496,
Brimonidine tartrateUK 14,304 tartrate,
AN-12800,
AS-18083,
AB0021226,
LS-177484,
ST24046243,
W0014,
A19740,
D02076,
359B465,
brimonidine tartrate (1:1), (S-(R*,R*))-isomer,
(4,5-Bihydro-1H-imidazol-2-yl)quinoxalin-6-amine L-tartrate,
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine tartrate,
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-Tartrate,
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1),
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1),
brimonidine,
Alphagan P,
mirvaso,
Lumify,
UK 14,304 tartrate,
D00ARM,
CID54405,
CS-O-03921,
C11-H10-Br-N5.C4-H6-O6,
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline,
A13433,
Brimonidine tartrate, 98.5% - 100MG 100mg,
79570-19-7,
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate (1:1),
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate,
59803-98-4,
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine(2R,3R)-2,3-dihydroxysuccinate,
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),